Skip to main content

RETRACTION article

Front. Oncol., 07 September 2021
Sec. Women's Cancer
Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.759578

Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways

This article is a retraction of:

  1. RETRACTED: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways

    1. Read original article
Frontiers Editorial Office* Frontiers Editorial Office*
  • Frontiers Media SA, Lausanne, Switzerland

A Retraction of the Original Research Article
Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways

By Gupta I, Zhang S, Jabeen A, Vranic S, Moustafa AEA, and Thawad HA (2021). Front. Oncol. doi: 10.3389/fonc.2021.630408

The Journal and Authors retract the 12 March 2021 article cited above for the following reasons provided by the Authors:

Following publication, concerns were raised regarding the integrity of the images in the published figures. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies.

This retraction was approved by the Chief Editors of Frontiers in Oncology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Citation: Frontiers Editorial Office (2021) Retraction: Oncoproteins of High-Risk HPV and EBV Cooperate to Enhance Cell Motility and Invasion of Human Breast Cancer Cells via Erk1/Erk2 and β-Catenin Signaling Pathways. Front. Oncol. 11:759578. doi: 10.3389/fonc.2021.759578

Received: 16 August 2021; Accepted: 16 August 2021;
Published: 07 September 2021.

Approved by:

Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2021 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Frontiers Editorial Office, editorial.office@frontiersin.org

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.